CLINICAL SIGNIFICANCE OF BIOMARKERS IN OVARIAN CANCER, PROSTATE CANCER, COLORECTAL CANCER

N. V. Marshutina; M. P. Solokhina; I. I. Alentov; N. S. Sergeeva

doi:10.17709/2409-2231-2016-3-1-7

Issledovaniâ i Praktika v Medicine (Mar 2016)

CLINICAL SIGNIFICANCE OF BIOMARKERS IN OVARIAN CANCER, PROSTATE CANCER, COLORECTAL CANCER

N. V. Marshutina,
M. P. Solokhina,
I. I. Alentov,
N. S. Sergeeva

Affiliations

N. V. Marshutina: P. Hertsen Moscow Oncology Research Institute – b ranch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation (Moscow, Russia) 3, 2nd Botkinskiy proezd, Moscow, 125284, Russia
M. P. Solokhina: P. Hertsen Moscow Oncology Research Institute – b ranch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation (Moscow, Russia) 3, 2nd Botkinskiy proezd, Moscow, 125284, Russia
I. I. Alentov: P. Hertsen Moscow Oncology Research Institute – b ranch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation (Moscow, Russia) 3, 2nd Botkinskiy proezd, Moscow, 125284, Russia
N. S. Sergeeva: P. Hertsen Moscow Oncology Research Institute – b ranch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation (Moscow, Russia) 3, 2nd Botkinskiy proezd, Moscow, 125284, Russia FBEI HPE "Pirogov Russian National Research Medical University" the Ministry of Health of the Russian Federation (Moscow, Russia) 1, ul. Ostrovityanova, Moscow, 117997, Russia

DOI: https://doi.org/10.17709/2409-2231-2016-3-1-7
Journal volume & issue: Vol. 3, no. 1
pp. 46 – 57

Abstract

Read online

The review is devoted to modern notions about serum tumor markers and their place in oncology: using for differential diagnosis, in prognosis of course of tumor process, during follow-up, for preclinical detection of disease recurrences, as well as in screening aimed at early detection of malignant neoplasms. Algorithms of using of most informative tumor markers: CA125, HE4 (in ovarian cancer), PSA and its isoforms (in prostate cancer), iFOBT (in colorectal cancer) were described.

Published in Issledovaniâ i Praktika v Medicine

ISSN: 2409-2231 (Print); 2410-1893 (Online)
Publisher: QUASAR, LLC
Country of publisher: Russian Federation
LCC subjects: Medicine
Website: http://www.rpmj.ru/rpmj

About the journal

Abstract

Keywords